The Ki-1 antibody was consistently reactive against poorly classified non-Hodgkin lymphomas that collectively exhibited abundant cytoplasm, large irregular nuclei and a tendency toward intrasinusoidal invasion. This evidence concerns the gene TNFRSF8 and non-Hodgkin lymphoma.